ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC (RETHYMIC) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC

What is the Trade Name for ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC

RETHYMIC

What is the Indication for ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC

  • 1 INDICATIONS AND USAGE RETHYMIC ¬Æ is indicated for immune reconstitution in pediatric patients with congenital athymia. RETHYMIC is indicated for immune reconstitution in pediatric patients with congenital athymia. ( 1 ) Limitations of Use : RETHYMIC is not indicated for the treatment of patients with severe combined immunodeficiency (SCID). Limitations of Use RETHYMIC is not indicated for the treatment of patients with severe combined immunodeficiency (SCID).

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]